Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tianxia Lan

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Molecular Cancer|March 12, 2022
Genome editing via non-viral delivery platforms: current progress in personalized cancer therapyTianxia Lan, Haiying Que, Min Luo, et al.
Medcomm|May 24, 2024
CD44 and its implication in neoplastic diseasesYiming Xu, Ziyi Bai, Tianxia Lan, et al.
Frontiers in Cell and Developmental Biology|June 14, 2021
Antitumor and Radiosensitization Effects of a CXCR2 Inhibitor in Nasopharyngeal CarcinomaXiaobei Liu, Tianxia Lan, Fei Mo, et al.
Signal Transduction and Targeted Therapy|January 3, 2024
Correction: The Hippo signalling pathway and its implications in human health and diseasesMinyang Fu, Yuan Hu, Tianxia Lan, et al.
Signal Transduction and Targeted Therapy|November 8, 2022
The Hippo signalling pathway and its implications in human health and diseasesMinyang Fu, Yuan Hu, Tianxia Lan, et al.
Cell Biology and Toxicology|June 25, 2021
Crystalline silica induces macrophage necrosis and causes subsequent acute pulmonary neutrophilic inflammationWen Nie, Tianxia Lan, Xia Yuan, et al.
ACS Nano|August 26, 2024
Nanoplatform Based Intranasal Vaccines: Current Progress and Clinical ChallengesZiyi Bai, Dandan Wan, Tianxia Lan, et al.
Medcomm|March 23, 2022
SARS-CoV-2 Omicron variant: Immune escape and vaccine developmentDanyi Ao, Tianxia Lan, Xuemei He, et al.
Nano Letters|September 17, 2021
Lymph-Node-Targeted Cholesterolized TLR7 Agonist Liposomes Provoke a Safe and Durable Antitumor ResponseDandan Wan, Haiying Que, Li Chen, et al.
Cancer Letters|December 5, 2022
ERK inhibitor: A candidate enhancing therapeutic effects of conventional chemo-radiotherapy in esophageal squamous cell carcinomaYanlin Song, Yuan Cheng, Tianxia Lan, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Molecular Cancer|March 12, 2022
Genome editing via non-viral delivery platforms: current progress in personalized cancer therapyTianxia Lan, Haiying Que, Min Luo, et al.
Medcomm|May 24, 2024
CD44 and its implication in neoplastic diseasesYiming Xu, Ziyi Bai, Tianxia Lan, et al.
Frontiers in Cell and Developmental Biology|June 14, 2021
Antitumor and Radiosensitization Effects of a CXCR2 Inhibitor in Nasopharyngeal CarcinomaXiaobei Liu, Tianxia Lan, Fei Mo, et al.
Signal Transduction and Targeted Therapy|January 3, 2024
Correction: The Hippo signalling pathway and its implications in human health and diseasesMinyang Fu, Yuan Hu, Tianxia Lan, et al.
Signal Transduction and Targeted Therapy|November 8, 2022
The Hippo signalling pathway and its implications in human health and diseasesMinyang Fu, Yuan Hu, Tianxia Lan, et al.
Cell Biology and Toxicology|June 25, 2021
Crystalline silica induces macrophage necrosis and causes subsequent acute pulmonary neutrophilic inflammationWen Nie, Tianxia Lan, Xia Yuan, et al.
ACS Nano|August 26, 2024
Nanoplatform Based Intranasal Vaccines: Current Progress and Clinical ChallengesZiyi Bai, Dandan Wan, Tianxia Lan, et al.
Medcomm|March 23, 2022
SARS-CoV-2 Omicron variant: Immune escape and vaccine developmentDanyi Ao, Tianxia Lan, Xuemei He, et al.
Nano Letters|September 17, 2021
Lymph-Node-Targeted Cholesterolized TLR7 Agonist Liposomes Provoke a Safe and Durable Antitumor ResponseDandan Wan, Haiying Que, Li Chen, et al.
Cancer Letters|December 5, 2022
ERK inhibitor: A candidate enhancing therapeutic effects of conventional chemo-radiotherapy in esophageal squamous cell carcinomaYanlin Song, Yuan Cheng, Tianxia Lan, et al.
Pageof 3